Topic Archives: Varian Medical (VAR)

“1+1=4” and “The Universal Cancer Cure” — What’s Stansberry’s Dave Lashmet talking about in his latest ads?

Dave Lashmet has been a biotech/medical analyst and sometimes a newsletter editor at Stansberry for a long time, and the latest iteration of his high-end newsletter is now called Stansberry Venture Technology (currently “on sale” for $2,500, no refunds)… and it’s now being promoted with a “cure for cancer” spiel, so we obviously all want […]

Comments

  • Gui_

    Varian Medical Systems (NYSE:VAR), which uses klystrons in radiation therapy devices, had $3 billion in sales last year....

  • Gui_

    Varian Medical Systems, Inc. (VAR) seems like significant news for treatment of tumors, posted in my support group yeste...

  • Avatar

    Robert - here is my take on those three companies. But, I would prefer if one of our esteemed docs offered a more profe...

  • Avatar

    Regarding Oxford's Teaser for Varian Medical. Travis, this one sure looked familiar. Remembered why - almost the sam...

  • Avatar

    Actually....I don't think this tease is intended to be Accuray... I believe it's intended company is: Varia...

  • Avatar

    I think Varian Medical is way out in front of these people. They have a radiation projection device "IMRT"which not...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch